Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Retraction Note: Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

The Original Article was published on 31 May 2009

Nat. Immunol. 10, 778–785 (2009); published online 31 May 2009; retracted 12 July 2013

Despite many attempts to replicate these results, the authors have been unable to confirm the original data showing that IL-17 alone or in combination with B cell–activating factor controls the survival of human B cells (Fig. 1a,b). Because this weakens the conclusions of the paper, all the authors (except A.D. and P.T., who could not be contacted) now retract this paper.

Authors

Additional information

The online version of the original article can be found at 10.1038/ni.1741

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Doreau, A., Belot, A., Bastid, J. et al. Retraction Note: Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 15, 894 (2014). https://doi.org/10.1038/ni0914-894a

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing